Evaluating the GCN5b bromodomain as a novel therapeutic target against the parasite Toxoplasma gondii.

Hanquier, Jocelyne; Gimeno, Thomas; Jeffers, Victoria; Sullivan, William J

Hanquier, Jocelyne; Gimeno, Thomas; Jeffers, Victoria; Sullivan, William J.

Afiliação

Hanquier J; Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.
Gimeno T; Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.
Jeffers V; Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.
Sullivan WJ; Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: wjsulliv@iu.edu.

Exp Parasitol ; 211: 107868, 2020 Feb 28.

Article em En | MEDLINE | ID: mdl-32119930

Palavras-chave

Bromodomain; Chromatin; Drug development; Epigenetics; Histone acetylation; Toxoplasma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Exp Parasitol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google